摘要: Metabolomics, or the comprehensive profiling of small molecule metabolites in cells, tissues, whole organisms, has undergone a rapid technological evolution past two decades. These advances have led to application metabolomics defining predictive biomarkers for incident cardiometabolic diseases and, increasingly, as blueprint understanding those diseases' pathophysiologic mechanisms. Progress this area and challenges future are reviewed here.